| | Title | Author(s) | Year | View Count | | 1 |  | Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks | Xu, A; Wang, Y; Renneberg Reinhard; Chan Puiyee Cangel; Lehmann Matthias | 2012 | 40 |
| 2 |  | LIPOCALIN-2 AS A PROGNOSTIC AND DIAGNOSTIC MARKER FOR HEART AND STROKE RISKS | Xu, A; Wang, Y; Renneberg, Reinhard; Chan, Puiyee, Cangel; Lehmann, Matthias | 2012 | 42 |
| 3 | | Method for decreasing blood glucose and improving glucose tolerance using angiopoietin-like protein 4 | Xu, A; Lam, KSL | 2012 | 45 |
| 4 | | USE OF LIPOCALIN-2 AS A DIAGNOSTIC MARKER AND THERAPEUTIC TARGET | Xu, A; Wang, Y; Lam, KSL; Lam, KSL | 2012 | 44 |
| 5 | | Lipocalin-2 As A Prognostic and Diagnostic Marker For Heart And Stroke Risks | Xu, A; Wang, Y; Renneberg Reinhard; Chan Cangel Pui Yee; Lehmann Matthias | 2012 | 48 |
| 6 | | USE OF LIPOCALIN-2 AS A DIAGNOSTIC MARKER AND THERAPEUTIC TARGET | Xu, A; Wang, Y; Lam, KSL | 2012 | 44 |
| 7 | | USE OF LIPOCALIN-2 AS A DIAGNOSTIC MARKER AND THERAPEUTIC TARGET | Xu, A; Wang, Y; Lam, KSL; Lam, KSL | 2012 | 40 |
| 8 | | USE OF LIPOCALIN-2 AS A DIAGNOSTIC MARKER AND THERAPEUTIC TARGET | Xu, A; Wang, Y; Lam, KSL | 2012 | 41 |
| 9 | | LIPOCALIN-2 AS A PROGNOSTIC AND DIAGNOSTIC MARKER FOR HEART AND STROKE RISKS | Xu, A; Wang, Y; Renneberg, Reinhard; Chan, Puiyee, Cangel; Lehmann, Matthias | 2012 | 60 |
| 10 | | Lipocalin-2 As A Prognostic And Diagnostic Marker For Heart And Stroke Risks | Wang, Y; Wang, Y; Xu, A | 2012 | 55 |
| 11 |  | Method For Decreasing Blood Glucose And Improving Glucose Tolerance Using Angiopoietin-Like Protein 4 | Lam, Karen Siu Ling; Xu, Aimin | - | 109 |
| 12 | | Lipocalin-2 As A Prognostic And Diagnostic Marker For Heart And Stroke Risks | Xu, Aimin; Wang, Yu; Xu, Aimin; Cautherley, George William Hunter; Chan, Cangel Pui Yee; Lehmann, Matthias | - | 159 |
|
